Related Experiment Videos
[Hyperlipidemia and osteoarticular manifestations].
P Goupille1, D Soutif, B Fouquet
1Service de Rhumatologie, CHU Trousseau.
La Revue De Medecine Interne
|March 1, 1991
Summary
Hyperlipoproteinaemia, particularly types II and IV, can cause musculoskeletal issues like arthritis and tendinitis. Lipid-lowering drugs may also lead to myalgias.
Area of Science:
- Rheumatology
- Endocrinology
- Metabolic Disorders
Context:
- Hyperlipoproteinaemia, specifically types II and IV, is linked to diverse musculoskeletal conditions.
- Arthralgias, arthritis, and tendinitis are common, especially in severe type IIa hyperlipoproteinaemia.
- Skeletal lesions are rare, but gout and osteonecrosis are associated with hyperlipidaemia.
Purpose:
- To explore the association between hyperlipoproteinaemia and musculoskeletal disorders.
- To detail the specific rheumatological manifestations linked to different types of hyperlipoproteinaemia.
- To discuss drug-induced musculoskeletal side effects.
Summary:
- Type II and IV hyperlipoproteinaemia can manifest as various joint and tendon disorders, potentially due to microcrystalline pathology.
- While skeletal lesions like xanthomas are rare, conditions such as gout and aseptic osteonecrosis frequently co-occur with hyperlipidaemia.
- Secondary hyperlipidaemia from other diseases and drug-induced myalgias from lipid-lowering therapies (fibrates, statins) are also noted.
Impact:
- Highlights the importance of considering hyperlipoproteinaemia in patients with unexplained musculoskeletal symptoms.
- Informs clinicians about potential rheumatological complications associated with lipid metabolism disorders.
- Raises awareness of drug-induced myalgias as a side effect of lipid-lowering treatments.